Figure 3From: Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees Kaplan-Meier analysis of days to CV event in SPAA and CCB/statin primary prevention patients with no history of cancer or chronic renal failure Back to article page